Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tirohia
    Member
    • Nov 2011
    • 47

    #1

    Too many samples

    So I've been given transcriptome data for ... quite a lot of samples (>500). It's all from various tumours from one specific tumour type. There's a clinical grading for how serious each tumour is.

    My concern is that, given it's cancer, within the groups formed by the clinical grading, there's probably a fair amount of variability. Which means that if we attempt differential expression analysis, then it's possible (likely?) that the differences within the clinical grading could obscure the differences between the groups.

    If one is looking for the best way to identify several different sets of genes for each clinical grading group, so as to be able to identify them, what's the best approach? My initial thoughts involve some form of clustering to identify sub groups within each clinical grading, but without knowing which genes to look at beforehand, that's going to end up with me attempting to cluster 20,000 odd genes, which, if I recall correctly, would be prohibitive, time-wise.

    What's the best approach for this sort of thing?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...